LY-341495

From WikiMD's WELLNESSPEDIA


Overview[edit]

LY-341495 is a potent and selective antagonist of the metabotropic glutamate receptor (mGluR) subtypes. It is primarily used in research to study the role of these receptors in various neurological processes and disorders.

Chemical Structure[edit]

Chemical structure of LY-341495

LY-341495 is a bicyclic compound with a unique structure that allows it to selectively bind to mGluR subtypes. Its chemical formula is C11H9NO4, and it is known for its high affinity and specificity.

Mechanism of Action[edit]

LY-341495 functions as an antagonist by binding to the glutamate receptor sites, thereby inhibiting the action of the neurotransmitter glutamate. This inhibition can modulate synaptic transmission and has implications for understanding neurotransmission and neuroplasticity.

Research Applications[edit]

LY-341495 is extensively used in neuroscience research to explore the role of mGluRs in various conditions such as epilepsy, schizophrenia, and anxiety disorders. Its ability to selectively block specific mGluR subtypes makes it a valuable tool for dissecting the complex signaling pathways involved in these disorders.

Pharmacokinetics[edit]

The pharmacokinetic profile of LY-341495 is characterized by its ability to cross the blood-brain barrier, making it effective in central nervous system studies. Its metabolism and excretion pathways are subjects of ongoing research to better understand its potential therapeutic applications.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.